Literature DB >> 23038084

Maximal medical therapy for chronic rhinosinusitis: a survey of otolaryngology consultants in the United Kingdom.

Deborah Claire Sylvester1, Simon Carr, Paul Nix.   

Abstract

BACKGROUND: The management of chronic rhinosinusitis is based on a trial of "maximal medical therapy" before surgery is considered. Ear-Nose-Throat (ENT) UK consultant members were surveyed to determine the role and variability of UK-wide practices.
METHODS: A survey was posted to all ENT UK consultant members (n = 603). This assessed the frequency of prescription, duration, and type of oral antibiotics, steroids, and antihistamines for chronic rhinosinusitis.
RESULTS: A total of 158 questionnaires (26.3%) were returned. Of these, 61% were primarily rhinologists. The use of decongestants, antifungals, and immunotherapy was generally limited. Oral antibiotics were often used, with clarithromycin of <5 weeks duration being the preferred choice. Sixty-one percent of consultants always prescribe a steroid spray, most commonly mometasone furoate (75%).
CONCLUSION: Although most respondents use triple therapy of oral antibiotics, steroid nasal spray, and saline douching to some extent, "maximal medical therapy" for chronic rhinosinusitis seems to vary greatly among consultants and frequently does not reflect recent guidelines.
© 2013 ARS-AAOA, LLC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23038084     DOI: 10.1002/alr.21084

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  7 in total

Review 1.  Is there a future for biologics in the management of chronic rhinosinusitis?

Authors:  Kent Lam; Robert C Kern; Amber Luong
Journal:  Int Forum Allergy Rhinol       Date:  2016-04-22       Impact factor: 3.858

2.  [Guideline for "rhinosinusitis"-long version : S2k guideline of the German College of General Practitioners and Family Physicians and the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery].

Authors:  B A Stuck; A Beule; D Jobst; L Klimek; M Laudien; M Lell; T J Vogl; U Popert
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

3.  Cost efficient workup and management of patients with chronic rhinosinusitis - challenges and unmet needs.

Authors:  Brian C Lobo; Jonathan Y Ting; Bruce K Tan
Journal:  Curr Otorhinolaryngol Rep       Date:  2015-06

4.  Medical Management Strategies in Acute and Chronic Rhinosinusitis.

Authors:  Seong H Cho; Dennis Ledford; Richard F Lockey
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-03

5.  Oral corticosteroid prescribing habits of Canadian Otolaryngologist-Head and Neck Surgeons.

Authors:  Saad Ansari; Brian W Rotenberg; Leigh J Sowerby
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-02-29

Review 6.  Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme).

Authors:  Helen Blackshaw; Jane Vennik; Carl Philpott; Mike Thomas; Caroline Eyles; James Carpenter; Caroline S Clarke; Steve Morris; Anne Schilder; Valerie Lund; Paul Little; Stephen Durham; Spiros Denaxas; Elizabeth Williamson; David Beard; Jonathan Cook; Steffi Le Conte; Kim Airey; Jim Boardman; Claire Hopkins
Journal:  Trials       Date:  2019-04-23       Impact factor: 2.279

7.  Topical therapy with high-volume budesonide nasal irrigations in difficult-to-treat chronic rhinosinusitis.

Authors:  Eduardo Macoto Kosugi; Guilherme Figner Moussalem; Juliana Caminha Simões; Rafael de Paula e Silva Felici de Souza; Vitor Guo Chen; Paulo Saraceni Neto; José Arruda Mendes Neto
Journal:  Braz J Otorhinolaryngol       Date:  2015-09-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.